Christopher Tapper is an experienced professional in the biopharmaceutical and life sciences sectors, currently serving as a Board Observer for Carrick Therapeutics, Epitopea, Microbiotica, Exvastat, and Mosaic Therapeutics, showcasing a focus on oncology and innovative therapies. Additionally, Christopher Tapper holds the position of Senior Investment Associate at Cambridge Innovation Capital, emphasizing investment opportunities in life sciences and technology. Previous roles include External Innovations Manager and Strategy Manager at C4X Discovery Ltd, as well as various consulting positions at L.E.K. Consulting, primarily in life sciences. Christopher Tapper also contributed to pharmaco-epidemiological research as a Research Assistant at the Centre for Public Health in Northern Ireland.
This person is not in the org chart
This person is not in any teams
This person is not in any offices